Ovarian endometriosis-associated stromal cells reveal persistently high affinity for iron

Redox Biology

Volumn 6, Issue , 2015, Pages 578-586

  Mori, Masahiko ^a   Ito, Fumiya ^a   Shi, Lei ^a   Wang, Yue ^a   Ishida, Chiharu ^a   Hattori, Yuka ^b   Niwa, Masato ^c   Hirayama, Tasuku ^c   Nagasawa, Hideko ^c   Iwase, Akira ^a   Kikkawa, Fumitaka ^a   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Ekisaikai Hospital   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Catalytic ferrous iron; Ferroportin; Ovarian endometriosis; Stromal cells; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; FERROPORTIN; IRON; TRANSFERRIN RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; IRON OVERLOAD; IRON TRANSPORT; MOLECULAR PROBE; OVARIAN ENDOMETRIOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STAINING; STROMA CELL; WESTERN BLOTTING; COCULTURE; METABOLISM; OVARY; OVARY DISEASE; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; ENDOMETRIOSIS; FEMALE; HUMANS; IRON; OVARIAN DISEASES; OVARY; RECEPTORS, TRANSFERRIN; STROMAL CELLS;

EID: 84944899667     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.10.001     Document Type: Article

References (43)

1. Burney R.O., Giudice L.C. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012, 98:511-519.
2. Giudice L.C., Kao L.C. Endometriosis. Lancet 2004, 364:1789-1799.
3. Bulun S.E. Endometriosis. N. Engl. J. Med. 2009, 360:268-279.
4. Kobayashi H., Sumimoto K., Moniwa N., Imai M., Takakura K., Kuromaki T., et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka Japan. Int. J. Gynecol. Cancer 2007, 17:37-43.
5. Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012, 13:385-394.
6. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009, 100:9-16.
7. Toyokuni S. Iron and thiols as two major players in carcinogenesis: friends or foes?. Front Pharmacol. 2014, 5.
8. Wriggleworth J.M., Baum H. The biochemical function of iron. Iron in Biochemistry and Medicine 1980, 29-86. Academic Press, London, II. A. Jacobs, M. Worwood (Eds.).
9. Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J. Am. Med. Asoc. 2004, 291:711-717.
10. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
11. HJH Fenton Oxidation of tartaric acid in presence of iron. J. Chem. Soc. 1894, 65:899-910
12. Leonard S.S., Harris G.K., Shi X. Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med. 2004, 37:1921-1942.
13. Toyokuni S., Sagripanti J.-L. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 1993, 14:223-227.
14. Toyokuni S., Mori T., Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int. J. Cancer 1994, 57:123-128.
15. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol. Int. 1999, 49:91-102.
16. Lee J.C., Son Y.O., Pratheeshkumar P., Shi X. Oxidative stress and metal carcinogenesis. Free Radic. Biol. Med. 2012, 53:742-757.
17. Yamaguchi K., Mandai M., Toyokuni S., Hamanishi J., Higuchi T., Takakura K., et al. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin. Cancer Res. 2008, 14:32-40.
18. Mandai M., Matsumura N., Baba T., Yamaguchi K., Hamanishi J., Konishi I. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett. 2011, 310:129-133.
19. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 1996, 20:553-566.
20. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New Engl. J. Med. 2012, 366:883-892.
21. Hirayama T., Okuda K., Nagasawa H. A highly selective turn-on fluorescent probe for iron (II) to visualize labile iron in living cells. Chem. Sci. 2013, 4:1250-1256.
22. Mukaide T., Hattori Y., Misawa N., Funahashi S., Jiang L., Hirayama T., et al. Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model. Free Radic. Res. 2014, 48:990-995.
23. Hattori Y., Mukaide T., Jiang L., Kotani T., Tsuda H., Mano Y., et al. Catalytic ferrous iron in amniotic fluid as a predictive marker of human maternal-fetal disorders. J. Clin. Biochem. Nutr. 2015, 56:57-63.
24. Niwa M., Hirayama T., Okuda K., Nagasawa H. A new class of high-contrast Fe(II) selective fluorescent probes based on spirocyclized scaffolds for visualization of intracellular labile iron delivered by transferrin. Org. Biomol. Chem. 2014, 12:6590-6597.
25. Orvis G.D., Behringer R.R. Cellular mechanisms of Mullerian duct formation in the mouse. Dev. Biol. 2007, 306:493-504.
26. Stewart C.A., Wang Y., Bonilla-Claudio M., Martin J.F., Gonzalez G., Taketo M.M., et al. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Mullerian duct and postnatal uterine development. Mol. Endocrinol. 2013, 27:1442-1454.
27. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007, 46:219-228.
28. Toyokuni S., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H., Stadtman E.R. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2616-2620.
29. Iwase A., Ando H., Nagasaka T., Shibata D., Harata T., Shimomura Y., et al. Neutral endopeptidase expressed by decidualized stromal cells suppresses akt phosphorylation and deoxyribonucleic acid synthesis induced by endothelin-1 in human endometrium. Endocrinology 2006, 147:5153-5159.
30. Yamashita Y., Tsurumi T., Mori N., Kiyono T. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability. Pathol. Int. 2006, 56:659-667.
31. Kobayashi H., Yamashita Y., Iwase A., Yoshikawa Y., Yasui H., Kawai Y., et al. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis. Fertil. Steril. 2012, 98(415-22). e1-12.
32. Suzuki Y., Shibata K., Kikkawa F., Kajiyama H., Ino K., Nomura S., et al. Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma. Clin. Cancer Res. 2003, 9:1528-1534.
33. 2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertil. Steril. 2012, 98(1001-8):e1.
34. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2007, Oxford University Press, New York. 4 ed.
35. Yamashita Y., Akatsuka S., Shinjo K., Yatabe Y., Kobayashi H., Seko H., et al. Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis. PLoS One 2013, 8:e57724.
36. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
37. Richardson D.R., Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1997, 1331:1-40.
38. Richardson D.R., Lane D.J., Becker E.M., Huang M.L., Whitnall M., Suryo Rahmanto Y., et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10775-10782.
39. Torti S.V., Torti F.M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 2013, 13:342-355.
40. Tanaka T., Kondo S., Iwasa Y., Hiai H., Toyokuni S. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Am. J. Pathol. 2000, 156:2149-2157.
41. Akatsuka S., Yamashita Y., Ohara H., Liu Y.T., Izumiya M., Abe K., et al. Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One 2012, 7:e43403.
42. Tseng J.F., Ryan I.P., Milam T.D., Murai J.T., Schriock E.D., Landers D.V., et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J. Clin. Endocrinol. Metab. 1996, 81:1118-1122.
43. Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic. Res. 2011, 45:906-917.